Factors affecting solubilization of a poorly soluble novel tubulin-binding agent

References

• Holmes F. Current status of clinical trials with paclitaxel and docetaxel in Taxane anticancer agents: Basic science and current status. Washington, DC: American Chemical Society, 1995.
   Google Scholar
• Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979;277:665–667.
   PubMed Web of Science ®Google Scholar
• Shah A, Wyandt C, Stodghill S. Physicochemical characterization of a novel anti-cancer agent and its comparison to Taxol®. Drug Dev Ind Pharm 2012:1–13 DOI: 10.3109/03639045.2012.659187.
   Web of Science ®Google Scholar
• Dahan A, Miller JM, Amidon GL. Prediction of solubility and permeability class membership: provisional BCS classification of the world’s top oral drugs. AAPS J 2009;11:740–746.
   PubMed Web of Science ®Google Scholar
• Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005;22:11–23.
   PubMed Web of Science ®Google Scholar
• Otsuka M, Kaneniwa N. Effects of grinding on the physicochemical properties of cephalexin. Chem Pharm Bull 1984;32:1071–1079.
   Web of Science ®Google Scholar
• Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods Find Exp Clin Pharmacol 1998;20:211–215.
   PubMed Web of Science ®Google Scholar
• ten Tije AJ, Verweij J, Loos WJ, Sparreboom A. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin Pharmacokinet 2003;42:665–685.
   PubMed Web of Science ®Google Scholar
• Ford JL. The current status of solid dispersions. Pharm Acta Helv 1986;61:69–88.
   PubMedGoogle Scholar
• Saito M, Ugajin T, Nozawa Y, Sadzuka Y, Miyagishima A, Sonobe T. Preparation and dissolution characteristics of griseofulvin solid dispersions with saccharides. Int J Pharm 2002;249:71–79.
   PubMed Web of Science ®Google Scholar
• Zia H, Ma JK, O’Donnell JP, Luzzi LA. Cosolvency of dimethyl isosorbide for steroid solubility. Pharm Res 1991;8:502–504.
   PubMed Web of Science ®Google Scholar
• Holvoet C, Heyden YV, Plaizier-Vercammen J. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use. Pharmazie 2005;60:598–603.
   PubMed Web of Science ®Google Scholar
• Ventura CA, Giannone I, Musumeci T, Pignatello R, Ragni L, Landolfi C et al. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies. Eur J Med Chem 2006;41:233–240.
   PubMed Web of Science ®Google Scholar
• Fleisher D, Bong R, Stewart B. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs. Adv Drug Deliver Rev 1996;19:115–130.
   Web of Science ®Google Scholar
• Thakkar H, Patel B, Thakkar S. A review of techniques for oral bioavailability enhancement of drugs. Int J Pharm Sci Rev Res 2010;4:033.
   Google Scholar
• Chang RK, Shojaei AH. Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures. Drug Dev Ind Pharm 2004;30:297–302.
   PubMed Web of Science ®Google Scholar
• Frank DW, Gray JE, Weaver RN. Cyclodextrin nephrosis in the rat. Am J Pathol 1976;83:367–382.
   PubMed Web of Science ®Google Scholar
• Law S, et al. Dissolution and absorption of nifedipine in polyethylene glycol solid dispersion containing phosphatidylcholine. Int J Pharm 1992;84:161–166.
   Web of Science ®Google Scholar
• Mooter V, et al. Physicochemical characterization of solid dispersion of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998;164:67–80.
   Web of Science ®Google Scholar
• Dannenfelser RM, He H, Joshi Y, Bateman S, Serajuddin AT. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004;93:1165–1175.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang GG, Neilly J, Marsh K, Mawhinney D, Sanzgiri YD. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68. Int J Pharm 2004;286:69–80.
   PubMed Web of Science ®Google Scholar
• Six K, Verreck G, Peeters J, Brewster M, Van Den Mooter G. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J Pharm Sci 2004;93:124–131.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G, Florence AT. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Drugs 1993;45:15–28.
   PubMed Web of Science ®Google Scholar
• Mohammed AR, Weston N, Coombes AG, Fitzgerald M, Perrie Y. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 2004;285:23–34.
   PubMed Web of Science ®Google Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamelle of swollen phospholipids. J Mol Biol 1965;13:325–328.
   PubMed Web of Science ®Google Scholar
• Joshi MR, Misra A. Liposomal budesonide for dry powder inhaler: preparation and stabilization. AAPS PharmSciTech 2001;2:25.
   PubMedGoogle Scholar
• Loftsson T, Jarho P, Másson M, Järvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2005;2:335–351.
   PubMed Web of Science ®Google Scholar
• McCandless R, Yalkowsky SH. Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl. J Pharm Sci 1998;87:1639–1642.
   PubMed Web of Science ®Google Scholar
• Satake I, Yoshida K, Hayakawa T, Meada T, Kusumoto Y. Conductimetric determination of the association constant of B-cyclodextrin with amphiphilic ions. Bull Chem Soc Japan 1986;59:3991–3993.
   Web of Science ®Google Scholar
• Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131–144.
   PubMed Web of Science ®Google Scholar
• Lesieur S, Grabielle-Madelmont C, Ménager C, Cabuil V, Dadhi D, Pierrot P et al. Evidence of surfactant-induced formation of transient pores in lipid bilayers by using magnetic-fluid-loaded liposomes. J Am Chem Soc 2003;125:5266–5267.
   PubMed Web of Science ®Google Scholar
• Gupta C, Daechsel AK, Chauhan A. Interaction of ionic surfactants with cornea-mimicking anionic liposomes. Langmuir 2011;27:10840–10846.
   PubMed Web of Science ®Google Scholar
• Layek B, Mukherjee B. Tamoxifen citrate encapsulated sustained release liposomes: preparation and evaluation of physicochemical properties. Sci Pharm 2010;78:507–515.
   PubMedGoogle Scholar
• Rieger M, Banker G. Lieberman H, ed. Liposomes. In: Pharmaceutical Dosage Forms: Disperse Systems. New York: Marcel Dekker, Inc., 1998, 43–86.
   Google Scholar
• Gregoriadis G. Physicochemical properties of phospholipids and lipit-water systems. In: Gregoriadis, G, ed., Liposome Technology: Preparation of Liposomes. Florida: CRC Press, Inc., 1984, 1–18.
   Google Scholar
• Chen C, Han D, Cai C, Tang X. An overview of liposome lyophilization and its future potential. J Control Release 2010;142:299–311.
   PubMed Web of Science ®Google Scholar